Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Seymour JF"'
Autor:
Minson A; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, Sydney, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.; School of Medicine, University of Western Australia, Crawley, Australia., Tam C; Clinical Haematology, Alfred Hospital, Melbourne, Australia., Blombery P; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Westerman D; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Ritchie D; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Morgan H; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Holzwart N; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Lade S; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia., Anderson MA; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Khot A; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Seymour JF; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Robertson M; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Caldwell I; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia., Ryland G; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Saghebi J; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia., Sabahi Z; Department of Haematology, St Vincent's Hospital, Sydney, Australia., Xie J; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia., Koldej R; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia., Dickinson M; Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia.
Publikováno v:
Blood [Blood] 2024 Feb 22; Vol. 143 (8), pp. 673-684.
Autor:
Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Cliff ERS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Tam CS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.; Alfred Hospital and Monash University, Melbourne, Australia., Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia., Bajel A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Ritchie D; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Khot A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Nov-Dec; Vol. 64 (11), pp. 1792-1800. Date of Electronic Publication: 2023 Aug 02.
Autor:
Wang ML; MD Anderson Cancer Center, Houston, TX., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli,' Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WA, Australia.; Medical School, University of Western Australia, Perth, WA, Australia., Ujjani CS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington., Koh Y; Seoul National University Hospital, Seoul, Korea., Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Gerson JN; University of Vermont, Burlington, VT., Flinn I; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Tessoulin B; Haematology Department, University Hospital, Nantes, France., Alencar AJ; Sylvester Comprehensive Cancer Center, Miami, FL., Ma S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Lewis D; Plymouth Hospitals NHS Trust-Derriford Hospital, Plymouth, United Kingdom., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Rhodes J; Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Uniondale, NY.; Northwell Health Cancer Institute Lake Success, New Hyde Park, NY., Patel K; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA., Maddocks K; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN., Tam CS; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia., Munir T; Department of Haematology, St James's University Hospital, Leeds, United Kingdom., Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan., Hernandez-Ilizaliturri F; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Kumar A; Memorial Sloan Kettering Cancer Center, New York, NY., Fenske TS; Medical College of Wisconsin, Milwaukee, WI., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY., Nair B; Loxo@Lilly, Indianapolis, IN., Tsai DE; Loxo@Lilly, Indianapolis, IN., Balbas M; Loxo@Lilly, Indianapolis, IN., Walgren RA; Loxo@Lilly, Indianapolis, IN., Abada P; Loxo@Lilly, Indianapolis, IN., Wang C; Eli Lilly and Company, Indianapolis, IN., Zhao J; Loxo@Lilly, Indianapolis, IN., Mato AR; Memorial Sloan Kettering Cancer Center, New York, NY., Shah NN; Medical College of Wisconsin, Milwaukee, WI.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 20; Vol. 41 (24), pp. 3988-3997. Date of Electronic Publication: 2023 May 16.
Autor:
Lew TE; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Minson A; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Dickinson M; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Handunnetti SM; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia., Blombery P; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Khot A; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Anderson MA; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Ritchie D; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Tam CS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia., Seymour JF; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. Electronic address: john.seymour@petermac.org.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Feb; Vol. 10 (2), pp. e142-e154.
Autor:
Rusconi C; Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cheah CY; Department of Hematology, Sir Charles Gairdner Hospital, Perth, Australia., Eyre TA; Oxford University Hospitals, NHS Foundation Trust, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom., Tucker D; Department of Haematology, Royal Cornwall Hospital NHS Trust, Truro, United Kingdom., Klener P; First Department of Internal Medicine-Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic., Giné E; Hematology Department, Hospital Clínic, Barcelona, Spain., Crucitti L; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Muzi C; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Iadecola S; Unit of Clinical Epidemiology and Trial Organization, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Infante G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Bernard S; APHP, Saint-Louis Hospital, Hemato-oncology Department, Paris & University of Paris, Diderot University, Paris, France., Auer RL; Centre for Haemato-Oncology, St.Bartholomew's Hospital Barts Health NHS Trust, London, United Kingdom., Pagani C; Divisione di Ematologia, ASST Spedali Civili, Brescia, Italy., Duglosz-Danecka M; Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Cracow, Poland., Mocikova H; Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University in Prague, Czech Republic., van Meerten T; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Cencini E; U.O.C. Ematologia, Ospedale Policlinico Santa Maria alle Scotte, Siena, Italy., Marin-Niebla A; Hematology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Williams ME; Hematology/Oncology Division, University of Virginia Cancer Center, Charlottesville, VA., Angelillo P; Lymphoma Unit Department of OncoHematology San Raffaele Scientific Institute, Milan, Italy., Nicoli P; SCDU Medicina Interna a Indirizzo Ematologico, AOU San Luigi Gonzaga, Orbassano, Italy., Arcari A; Haematology and Bone Marrow Transplant Unit, 'Guglielmo da Saliceto' Hospital, Piacenza, Italy., Morello L; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy., Mannina D; UOC di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy., Vitagliano O; Division of Hematology, Cardarelli Hospital, Napoli, Italy., Sartori R; Onco Hematology Unit, Istituto Oncologico Veneto IOV-IRCSS, Castelfranco Veneto, Italy., Chiappella A; Division of Hematology, A.O. Città della Salute e della Scienza di Torino, Torino, Italy., Sciarra R; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Stefani PM; U.O.C. di Ematologia, Dipartimento di Medicina Specialistica, Unità Locale Socio-Sanitaria della Marca Trevigiana, Treviso, Italy., Dreyling M; Department of Medicine III, LMU University Hospital, Munich, Germany., Seymour JF; Department of Hematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia., Visco C; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
Publikováno v:
Blood [Blood] 2022 Oct 27; Vol. 140 (17), pp. 1907-1916.
Autor:
Thompson ER; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Nguyen T; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia., Kankanige Y; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Markham JF; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; and.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia., Handunnetti SM; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Thijssen R; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; and., Yeh PS; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Tam CS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia., Seymour JF; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia., Roberts AW; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; and.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia., Westerman DA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Blombery P; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
Publikováno v:
Blood advances [Blood Adv] 2022 Jan 25; Vol. 6 (2), pp. 503-508.
Autor:
Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia. thomas.lew@petermac.org.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. thomas.lew@petermac.org., Cliff ERS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Tam CS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Bajel A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Ritchie D; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Khot A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2021 Nov; Vol. 56 (11), pp. 2857-2859. Date of Electronic Publication: 2021 Jul 20.
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachuetts. matthew_davids@dfci.harvard.edu., Roberts AW; Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia., Kenkre VP; Division of Hematology and Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin., Wierda WG; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas., Kumar A; Division of Hematology and Oncology, University of Arizona Cancer Center, Tuscon, Arizona., Kipps TJ; Division of Hematology-Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, San Diego, California., Boyer M; F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom., Salem AH; AbbVie Inc., North Chicago, Illinois., Pesko JC; AbbVie Inc., North Chicago, Illinois., Arzt JA; AbbVie Inc., North Chicago, Illinois., Mantas M; AbbVie Inc., North Chicago, Illinois., Kim SY; AbbVie Inc., North Chicago, Illinois., Seymour JF; Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4690-4695. Date of Electronic Publication: 2021 Jun 03.
Autor:
Jain P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Dreyling M; Medizinische Klinik III, Ludwig Maximilian University Klinikum München, München, Germany., Seymour JF; Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia., Wang M; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Dec 20; Vol. 38 (36), pp. 4302-4316. Date of Electronic Publication: 2020 Oct 19.
Autor:
Davis JE; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Handunnetti SM; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia., Ludford-Menting M; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Sharpe C; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Blombery P; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and., Anderson MA; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia.; Division of Cancer and Haematology, Walter and Eliza Hall Institute, Melbourne, VIC, Australia., Roberts AW; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia.; Division of Cancer and Haematology, Walter and Eliza Hall Institute, Melbourne, VIC, Australia., Seymour JF; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia., Tam CS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia., Ritchie DS; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia., Koldej RM; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
Publikováno v:
Blood advances [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4849-4859.